Financial Performance and Subsidiaries Revenue
FORMULATION FACILITIES
INTERNATIONAL MARKETS
DOMESTIC MARKETS
NATCO PHARMA LTD
NATCO
KOTHUR
TELANGANA
Oral and solid dosages including
dry powder, cytotoxic & non-
cytotoxic orals and cytotoxic
injectables.
USFDA, GMP, DCA, German
Health Authority, Australia TGA,
ANVISA (Brazil)
USFDA audit with Establishment
Inspection Report (EIR) received
in August 2019
VISAKAPATNAM
ANDHRA PRADESH
Solid oral tablet and capsule
manufacturing
Site approval received from
USFDA. ANVISA, Health Canada
Authority
Located in a Special Economic
Zone (SEZ)
USFDA audit with Establishment
Inspection Report (EIR) received
in June 2023
NAGARJUNASAGAR*
GUWAHATI
ASSAM
TELANGANA
Oncology, Antibiotics and
Antiviral
Tablets, Capsules
ANVISA (Brazil), WHO GMP and
Kenya MOH, EFMHACA-
Ethiopia, NMRA- Sri Lanka,
Health Canada
WHO-GMP, CDSCO Compliant
facility
DEHRADUN
UTTARAKHAND
Tablets, Capsules
GMP, WHO-GMP, Public Health
Service of the Netherlands (EU
GMP)
Approvals are there to service near regulatory markets as well
10View entire presentation